0001415889-22-007687.txt : 20220715
0001415889-22-007687.hdr.sgml : 20220715
20220715163027
ACCESSION NUMBER: 0001415889-22-007687
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220630
FILED AS OF DATE: 20220715
DATE AS OF CHANGE: 20220715
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smith Mark Alan
CENTRAL INDEX KEY: 0001677452
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37761
FILM NUMBER: 221087236
MAIL ADDRESS:
STREET 1: 343 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VistaGen Therapeutics, Inc.
CENTRAL INDEX KEY: 0001411685
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205093315
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 343 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-577-3600
MAIL ADDRESS:
STREET 1: 343 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: Excaliber Enterprises, Ltd.
DATE OF NAME CHANGE: 20070906
4
1
form4-07152022_040709.xml
X0306
4
2022-06-30
0001411685
VistaGen Therapeutics, Inc.
VTGN
0001677452
Smith Mark Alan
C/O VISTAGEN THERAPEUTICS, INC.
343 ALLERTON AVENUE
SOUTH SAN FRANCISCO
CA
94080
false
true
false
false
CHIEF MEDICAL OFFICER
Common Stock
2022-06-30
5
A
0
5000
0.7480
A
19915
D
Shares purchased under the VistaGen Therapeutics, Inc. 2019 Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c)
/s/ Jerrold D. Dotson, Attorney-in-Fact
2022-07-15